FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults

Auvelity is the first and only rapid-acting oral treatment approved with labeling of statistically significant improvement in depressive symptoms compared to placebo starting at one week11-4 Auvelity uses the first new oral mechanism of action...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news